Importance of the SARS-CoV-2 genome and spike protein in the immunopathogenesis of COVID-19 and in the efficacy of vaccines.

Autor: Jiménez-Morales S; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México., Pérez-Amado CJ; Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México., Montúfar-Robles I; Unidad de Investigación, Hospital Juárez de México, Ciudad de México., Fragoso JM; Departamento de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México., Aranda-Uribe IS; Departamento de Ciencias Farmacéuticas, Universidad Autónoma del Estado de Quintana Roo, Quintana Roo., Ramos-Puga DA; Unidad de Investigación, Hospital Juárez de México, Ciudad de México., Martínez-Flores ÁE; Unidad de Investigación, Hospital Juárez de México, Ciudad de México., Ramírez-Bello J; Departamento de Endocrinología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México. México.
Jazyk: angličtina
Zdroj: Cirugia y cirujanos [Cir Cir] 2023; Vol. 91 (2), pp. 268-276.
DOI: 10.24875/CIRU.22000547
Abstrakt: Coronavirus (CoV) infections cause respiratory and enteric diseases with clinical manifestations ranging from faint to severe, even lead to death of patients. High connectivity between nations and infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represent a global health problem as the coronavirus disease 19 (COVID-19). This CoV-2 that cause SARS, which appeared in Wuhan, China, in December 2019 originated COVID-19 and declared as pandemic a few months posterior its appearance. In this review, the genomic and spike protein characteristics of SARS-CoV-2, the role of SARS-CoV-2 in the COVID-19 pathogenesis, cytokine storm, the role of cytotoxic T and B cells against SARS-CoV-2, as well as the vaccines efficacy (taking into account mutations in the spike protein) are described.
(Copyright: © 2023 Permanyer.)
Databáze: MEDLINE